BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28045167)

  • 21. Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer.
    Chowdhury N; Vhora I; Patel K; Doddapaneni R; Mondal A; Singh M
    Pharm Res; 2017 Nov; 34(11):2371-2384. PubMed ID: 28875330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cationic liposomes co-deliver chemotherapeutics and siRNA for the treatment of breast cancer.
    Li M; Li S; Li Y; Li X; Yang G; Li M; Xie Y; Su W; Wu J; Jia L; Li S; Ma W; Li H; Guo N; Yu P
    Eur J Med Chem; 2022 Apr; 233():114198. PubMed ID: 35245829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice.
    Pastorino F; Brignole C; Marimpietri D; Sapra P; Moase EH; Allen TM; Ponzoni M
    Cancer Res; 2003 Jan; 63(1):86-92. PubMed ID: 12517782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.
    Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer.
    Zhou J; Zhao WY; Ma X; Ju RJ; Li XY; Li N; Sun MG; Shi JF; Zhang CX; Lu WL
    Biomaterials; 2013 May; 34(14):3626-38. PubMed ID: 23422592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo.
    Shi C; Cao H; He W; Gao F; Liu Y; Yin L
    Biomed Pharmacother; 2015 Jul; 73():48-57. PubMed ID: 26211582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.
    Eloy JO; Petrilli R; Topan JF; Antonio HMR; Barcellos JPA; Chesca DL; Serafini LN; Tiezzi DG; Lee RJ; Marchetti JM
    Colloids Surf B Biointerfaces; 2016 May; 141():74-82. PubMed ID: 26836480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural Particulates Inspired Specific-Targeted Codelivery of siRNA and Paclitaxel for Collaborative Antitumor Therapy.
    Wang R; Zhao Z; Han Y; Hu S; Opoku-Damoah Y; Zhou J; Yin L; Ding Y
    Mol Pharm; 2017 Sep; 14(9):2999-3012. PubMed ID: 28753317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes.
    Niu R; Zhao P; Wang H; Yu M; Cao S; Zhang F; Chang J
    J Drug Target; 2011 Jun; 19(5):373-81. PubMed ID: 20677917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.
    Garbuzenko OB; Saad M; Betigeri S; Zhang M; Vetcher AA; Soldatenkov VA; Reimer DC; Pozharov VP; Minko T
    Pharm Res; 2009 Feb; 26(2):382-94. PubMed ID: 18958402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer.
    Xiang B; Dong DW; Shi NQ; Gao W; Yang ZZ; Cui Y; Cao DY; Qi XR
    Biomaterials; 2013 Sep; 34(28):6976-91. PubMed ID: 23777916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug.
    Shim G; Han SE; Yu YH; Lee S; Lee HY; Kim K; Kwon IC; Park TG; Kim YB; Choi YS; Kim CW; Oh YK
    J Control Release; 2011 Oct; 155(1):60-6. PubMed ID: 20971142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation.
    Ravar F; Saadat E; Gholami M; Dehghankelishadi P; Mahdavi M; Azami S; Dorkoosh FA
    J Control Release; 2016 May; 229():10-22. PubMed ID: 26968799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.
    Jain S; Kumar D; Swarnakar NK; Thanki K
    Biomaterials; 2012 Oct; 33(28):6758-68. PubMed ID: 22748771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cationic liposomal co-delivery of small interfering RNA and a MEK inhibitor for enhanced anticancer efficacy.
    Kang SH; Cho HJ; Shim G; Lee S; Kim SH; Choi HG; Kim CW; Oh YK
    Pharm Res; 2011 Dec; 28(12):3069-78. PubMed ID: 21879387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Layer-by-layer assembly of chitosan stabilized multilayered liposomes for paclitaxel delivery.
    Chen MX; Li BK; Yin DK; Liang J; Li SS; Peng DY
    Carbohydr Polym; 2014 Oct; 111():298-304. PubMed ID: 25037355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.
    Loi M; Di Paolo D; Soster M; Brignole C; Bartolini A; Emionite L; Sun J; Becherini P; Curnis F; Petretto A; Sani M; Gori A; Milanese M; Gambini C; Longhi R; Cilli M; Allen TM; Bussolino F; Arap W; Pasqualini R; Corti A; Ponzoni M; MarchiĆ² S; Pastorino F
    J Control Release; 2013 Sep; 170(2):233-41. PubMed ID: 23714122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.
    Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q
    Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A targeting drug delivery system for ovarian carcinoma: transferrin modified lipid coated paclitaxel-loaded nanoparticles.
    Li R; Zhang Q; Wang XY; Chen XG; He YX; Yang WY; Yang X
    Drug Res (Stuttg); 2014 Oct; 64(10):541-7. PubMed ID: 24443309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.